The Company enters 2026 with Multiple Phase 2 Catalysts, AI-enabled drug development strategy, and regulatory optionality as ...
SpyGlass Pharma is pursuing a $100 million IPO to advance its glaucoma drug delivery platform through Phase 3 trials. Read ...
The funding will support a GLP-1 pill Corxel licensed from China-based Vincentage in 2024 and that the company believes to be ...
Dermatology in the near future will be characterized by digitally enabled, patient-centred research that reaches people where ...
Yee is joined by two other bullish analysts who are even more optimistic on the stock, earning it a Strong Buy consensus ...
The landscape of Philippine cinema is undergoing a considerable transformation, slowly transitioning from survival to ...
Detailed price information for Quartz Mountain Resources Ltd (QZMRF) from The Globe and Mail including charting and trades.
Completed a landmark $1 billion transaction1 on June 3, 2025, to acquire Barrick Mining Corporation’s (“Barrick”) 50% interest in Donlin Gold LLC ...
Stocktwits on MSN
Why is Cadrenal Therapeutics stock drawing retail attention today?
The company outlined progress on its anticoagulation pipeline, including its HIT program VLX-1005, at a Lytham Partners ...
Intuitive Surgical, Inc. ( ISRG) Q4 2025 Earnings Call January 22, 2026 4:30 PM EST Daniel Connally - VP & Head of Investor ...
VANCOUVER, BC / ACCESS Newswire / January 20, 2026 / Quartz Mountain Resources Ltd. (TSXV:QZM)(OTCQX:QZMRF) ("Quartz" or the "Company") is pleased to announce that it will be participating in AME Roun ...
If 2024 was the year of artificial intelligence (AI) hype, 2025 was the year of AI accountability. The legal landscape ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results